Cargando…

The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes

OBJECTIVE: Salsalate is a nonacetylated salicylate that lowers glucose levels in people with type 2 diabetes (T2D). Here we examined whether salsalate also lowered serum-protein-bound levels of early and advanced glycation end products (AGEs) that have been implicated in diabetic vascular complicati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barzilay, Joshua I., Jablonski, Kathleen A., Fonseca, Vivian, Shoelson, Steven E., Goldfine, Allison B., Strauch, Christopher, Monnier, Vincent M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2014
Materias:	Pathophysiology/Complications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964486/ https://www.ncbi.nlm.nih.gov/pubmed/24255104 http://dx.doi.org/10.2337/dc13-1527

Ejemplares similares

Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC
por: Monnier, Vincent M, et al.
Publicado: (2022)

Effect of Salsalate on Insulin Action, Secretion, and Clearance in Nondiabetic, Insulin-Resistant Individuals: A Randomized, Placebo-Controlled Study
por: Kim, Sun H., et al.
Publicado: (2014)

Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD)
por: Goldfine, Allison B., et al.
Publicado: (2013)

Glycation by glyoxal leads to profound changes in the behavior of dermal fibroblasts
por: Guillon, Cécile, et al.
Publicado: (2021)

TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)
por: Srinivasan, Shylaja, et al.
Publicado: (2018)

Response to Comment on Goldfine et al. Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes: Effects on Flow-Mediated Dilation (TINSAL-FMD). Diabetes Care 2013;36:4132–4139
por: Goldfine, Allison B., et al.
Publicado: (2014)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Skin Advanced Glycation End Products Glucosepane and Methylglyoxal Hydroimidazolone Are Independently Associated With Long-term Microvascular Complication Progression of Type 1 Diabetes
por: Genuth, Saul, et al.
Publicado: (2015)

Serum Trypsinogen Levels in Type 1 Diabetes
por: Li, Xia, et al.
Publicado: (2017)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Serum Levels of the Adipokine FGF21 Depend on Renal Function
por: Stein, Sebastian, et al.
Publicado: (2009)

Serum Xylosyltransferase Activity in Diabetic Patients as a Possible Marker of Reduced Proteoglycan Biosynthesis
por: Götting, Christian, et al.
Publicado: (2008)

Urine Leucine-Rich α-2 Glycoprotein 1 (LRG1) Predicts the Risk of Progression to End-Stage Kidney Disease in Patients With Type 2 Diabetes
por: Liu, Jian-Jun, et al.
Publicado: (2023)

Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus
por: Wang, Chuan, et al.
Publicado: (2022)

Glomerular filtration rate in patients with type 2 diabetes mellitus: is serum isthmin-1 level a possible link?
por: Xu, Mingyue, et al.
Publicado: (2023)

Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease
por: Yamanouchi, Masayuki, et al.
Publicado: (2021)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

Association between serum fibroblast growth factor 21 level and sight-threatening diabetic retinopathy in Chinese patients with type 2 diabetes
por: Jin, Shi, et al.
Publicado: (2021)

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes
por: Soro-Paavonen, Aino, et al.
Publicado: (2008)

Trends in the relation between hyperglycemia correction and active Charcot neuroarthropathy: results from the EPICHAR study
por: Dardari, Dured, et al.
Publicado: (2022)

Oxidation, Type 2 Diabetes, and Coronary Heart Disease: A Complex Interaction: Findings from a population-based study
por: Stranges, Saverio, et al.
Publicado: (2008)

Associations Between Exposure to Gestational Diabetes Mellitus In Utero and Daily Energy Intake, Brain Responses to Food Cues, and Adiposity in Children
por: Luo, Shan, et al.
Publicado: (2021)

Impact of Early Diabetic Ketoacidosis on the Developing Brain
por: Aye, Tandy, et al.
Publicado: (2019)

Type 1 Diabetes Is Associated With an Increased Risk of Fracture Across the Life Span: A Population-Based Cohort Study Using The Health Improvement Network (THIN)
por: Weber, David R., et al.
Publicado: (2015)

Acute and chronic neuroinflammation is triggered by diabetic ketoacidosis in a rat model
por: Glaser, Nicole, et al.
Publicado: (2020)

Effects of TRAM-34 and minocycline on neuroinflammation caused by diabetic ketoacidosis in a rat model
por: Glaser, Nicole, et al.
Publicado: (2022)

Skin autofluorescence predicts cancer in subjects with type 2 diabetes
por: Foussard, Ninon, et al.
Publicado: (2021)

Sickle Cell Trait Worsens Oxidative Stress, Abnormal Blood Rheology, and Vascular Dysfunction in Type 2 Diabetes
por: Diaw, Mor, et al.
Publicado: (2015)

Consistent Effects of Hypoglycemia on Cognitive Function in People With or Without Diabetes
por: Verhulst, Clementine E.M., et al.
Publicado: (2022)

Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
por: Reiniger, Nina, et al.
Publicado: (2010)

Risk Factors Related to Inflammation and Endothelial Dysfunction in the DCCT/EDIC Cohort and Their Relationship With Nephropathy and Macrovascular Complications
por: Lopes-Virella, Maria F., et al.
Publicado: (2008)

Testosterone Concentration in Young Patients With Diabetes
por: Chandel, Anil, et al.
Publicado: (2008)

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2008)

Pregnancy Insulin, Glucose, and BMI Contribute to Birth Outcomes in Nondiabetic Mothers
por: Ong, Ken K., et al.
Publicado: (2008)

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial
por: Kilpatrick, Eric S., et al.
Publicado: (2008)

Euglycemic Hyperinsulinemia Alters the Response to Orthostatic Stress in Older Adults With Type 2 Diabetes
por: Madden, Kenneth M., et al.
Publicado: (2008)

Insulin Administration and Rate of Glucose Appearance in People With Type 1 Diabetes
por: Pennant, Mary E., et al.
Publicado: (2008)

Adipose Tissue Lipolysis Is Upregulated in Lean and Obese Men During Acute Resistance Exercise
por: Chatzinikolaou, Athanasios, et al.
Publicado: (2008)

Trends in High-Risk HLA Susceptibility Genes Among Colorado Youth With Type 1 Diabetes
por: Vehik, Kendra, et al.
Publicado: (2008)

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes
por: Brown, Rebecca J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_rk6k1gi9ifvkgcr9c0phf4av9d